Healthcare provider profile · identity verified

Brendon Patrick Smith, DO

Family Practice · KALISPELL, MT · NPI 1720490907

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	361	82
Amlodipine Besylate	Amlodipine Besylate	306	84
Atorvastatin Calcium	Atorvastatin Calcium	279	84
Levothyroxine Sodium	Levothyroxine Sodium	276	65
Omeprazole	Omeprazole	270	76
Losartan Potassium	Losartan Potassium	238	63
Tamsulosin Hcl	Tamsulosin Hcl	234	61
Lisinopril	Lisinopril	215	57
Gabapentin	Gabapentin	213	44
Metformin Hcl Er	Metformin Hcl	146	45
Simvastatin	Simvastatin	127	28
Hydrochlorothiazide	Hydrochlorothiazide	121	27
Escitalopram Oxalate	Escitalopram Oxalate	111	20
Metoprolol Succinate	Metoprolol Succinate	105	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	35
Allopurinol	Allopurinol	94	27
Eliquis	Apixaban	86	17
Alprazolam	Alprazolam	85	13
Lorazepam	Lorazepam	84	17
Metformin Hcl	Metformin Hcl	81	22
Albuterol Sulfate Hfa	Albuterol Sulfate	78	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	18
Metoprolol Tartrate	Metoprolol Tartrate	78	21
Montelukast Sodium	Montelukast Sodium	74	16
Meloxicam	Meloxicam	70	22
Tramadol Hcl	Tramadol Hcl	69	18
Alendronate Sodium	Alendronate Sodium	67	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	13
Potassium Chloride	Potassium Chloride	67	17
Carvedilol	Carvedilol	66	16
Duloxetine Hcl	Duloxetine Hcl	58	12
Ozempic	Semaglutide	57	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	15
Pantoprazole Sodium	Pantoprazole Sodium	55	17
Finasteride	Finasteride	50	14
Methocarbamol	Methocarbamol	50	11
Sertraline Hcl	Sertraline Hcl	50	14
Fluoxetine Hcl	Fluoxetine Hcl	49	suppressed
Trazodone Hcl	Trazodone Hcl	49	20
Furosemide	Furosemide	47	13
Clonazepam	Clonazepam	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	14
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Glimepiride	Glimepiride	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	11
Mounjaro	Tirzepatide	32	suppressed
Atenolol	Atenolol	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Prednisone	Prednisone	31	19
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Ondansetron Odt	Ondansetron	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Baclofen	Baclofen	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Famotidine	Famotidine	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	20
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Eszopiclone	Eszopiclone	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Glipizide	Glipizide	20	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Estradiol	Estradiol	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Valsartan	Valsartan	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Torsemide	Torsemide	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	11
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Primidone	Primidone	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Temazepam	Temazepam	11	suppressed
Tramadol Hcl Er	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error